Select Publications
Book Chapters
2014, 'Pemphigus', in Evidence-Based Dermatology: Third Edition, pp. 552 - 560, http://dx.doi.org/10.1002/9781118357606.ch65
,Journal articles
2024, 'Implementing systematic melanoma risk assessment and risk-tailored surveillance in a skin cancer focussed dermatology clinic: A qualitative study of feasibility and acceptability to patients and clinic staff', Cancer Medicine, 13, http://dx.doi.org/10.1002/cam4.6976
,2023, 'Supportive care needs in Australian melanoma patients and caregivers: results from a quantitative cross-sectional survey', Quality of Life Research, 32, pp. 3531 - 3545, http://dx.doi.org/10.1007/s11136-023-03492-0
,2023, 'Definitive treatment with PD-1 blockade and radiation therapy of unresected primary desmoplastic melanoma of the nose', Melanoma Research, 33, pp. 422 - 424, http://dx.doi.org/10.1097/CMR.0000000000000905
,2023, 'An adapter window for precise skin marking during handheld reflectance confocal microscopic scanning', Journal of the American Academy of Dermatology, 89, pp. e125 - e126, http://dx.doi.org/10.1016/j.jaad.2021.11.064
,2023, 'Reply to: ‘Melanoma diagnosis at a specialist dermatology practice without the use of photographic surveillance’', Australasian Journal of Dermatology, 64, pp. e307 - e308, http://dx.doi.org/10.1111/ajd.14087
,2023, 'A phase 2 study to determine the pathological (path) response to neoadjuvant nivolumab (nivo) and relatlimab (rela) in high-risk stage II cutaneous melanoma: NeoReNi II.', Journal of Clinical Oncology, 41, pp. TPS9610 - TPS9610, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps9610
,2023, 'Reflectance confocal microscopy in Australia: Perspectives on barriers to implementation and uptake', Australasian Journal of Dermatology, 64, pp. e109 - e111, http://dx.doi.org/10.1111/ajd.13954
,2023, 'From the Cochrane Library: Interventions for Pemphigus Vulgaris and Pemphigus Foliaceus', JMIR Dermatology, 6, http://dx.doi.org/10.2196/46812
,2023, '396 A novel investigator global assessment score for the evaluation of keratosis pilaris', Journal of Investigative Dermatology, 143, pp. S68 - S68, http://dx.doi.org/10.1016/j.jid.2023.03.402
,2022, 'Utility of optical coherence tomography in basal cell naevus syndrome: A case report', Australasian Journal of Dermatology, 63, pp. e331 - e335, http://dx.doi.org/10.1111/ajd.13921
,2022, 'Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment', Dermatologic Therapy, 35, http://dx.doi.org/10.1111/dth.15472
,2022, 'Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy', Journal of the European Academy of Dermatology and Venereology, 36, pp. e445 - e448, http://dx.doi.org/10.1111/jdv.17940
,2022, '‘Home-school toes’ – a case series of paediatric perniosis presentations', Australasian Journal of Dermatology, 63, pp. 256 - 258, http://dx.doi.org/10.1111/ajd.13827
,2022, 'Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma', BMJ open, 12, pp. e054337, http://dx.doi.org/10.1136/bmjopen-2021-054337
,2022, 'Optical coherence tomography features of a tumour of the follicular infundibulum', Australasian Journal of Dermatology, 63, pp. 133 - 135, http://dx.doi.org/10.1111/ajd.13747
,2022, 'An unusual growth in the nail matrix: A case of superficial acral fibromyxoma.', Skin Health Dis, 2, pp. e121, http://dx.doi.org/10.1002/ski2.121
,2021, 'Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children', Pediatric Dermatology, 38, pp. 1549 - 1552, http://dx.doi.org/10.1111/pde.14846
,2021, 'Longitudinal melanonychia striata mimicking a melanoma during pregnancy', Australasian Journal of Dermatology, 62, pp. e451 - e453, http://dx.doi.org/10.1111/ajd.13590
,2021, 'A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', JAAD International, 2, pp. 134 - 152, http://dx.doi.org/10.1016/j.jdin.2020.12.007
,2021, '157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Journal of Investigative Dermatology, 141, pp. S28 - S28, http://dx.doi.org/10.1016/j.jid.2021.02.177
,2020, 'Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts', Journal of the American Academy of Dermatology, 83, pp. 1222 - 1224, http://dx.doi.org/10.1016/j.jaad.2020.06.1023
,2019, 'Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation', JAAD Case Reports, 5, pp. 491 - 494, http://dx.doi.org/10.1016/j.jdcr.2019.04.006
,2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271
,2014, 'Diffuse melanosis cutis in the setting of BRAFV600E metastatic melanoma', International Journal of Dermatology, 53, pp. 1409 - 1411, http://dx.doi.org/10.1111/ijd.12614
,2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972
,2013, 'Diffuse melanosis cutis: A systematic review of the literature', Journal of the American Academy of Dermatology, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018
,2011, 'A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus', Journal of the American Academy of Dermatology, 64, pp. 903 - 908, http://dx.doi.org/10.1016/j.jaad.2010.04.039
,2010, 'Erratum: Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument (British Journal of Dermatology (2009) 161 (1323-1330))', British Journal of Dermatology, 162, pp. 701, http://dx.doi.org/10.1111/j.1365-2133.2010.09642.x
,2009, 'Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument', British Journal of Dermatology, 161, pp. 1323 - 1330, http://dx.doi.org/10.1111/j.1365-2133.2009.09347.x
,2009, 'Dapsone hypersensitivity syndrome causing disseminated intravascular coagulation', BMJ Case Reports, http://dx.doi.org/10.1136/bcr.11.2008.1257
,2009, 'Pemphigus', , pp. 581 - 594, http://dx.doi.org/10.1002/9781444300161.ch58
,2009, 'Chronic localized intravascular coagulation complicating multifocal venous malformations', Australasian Journal of Dermatology, 50, pp. 276 - 280
,2009, 'Interventions for pemphigus vulgaris and pemphigus foliaceus', Cochrane Database of Systematic Reviews, pp. 1 - 73
,2009, 'Naevus of Ota presenting in two generations: A mother and daughter', Journal of the European Academy of Dermatology and Vernereology, 23, pp. 102 - 104
,2008, 'Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus', Journal of the American Academy of Dermatology, 58, pp. 1043 - 1046, http://dx.doi.org/10.1016/j.jaad.2008.01.012
,2008, 'Development of a quality of life measure specific for epidermolysis bullosa', Journal of Investigative Dermatology, 128, pp. S80 - S80
,2008, 'Podophyllin reaction mimicking Bowen`s disease in a patient with delusions of verrucosis', Clinical and Experimental Dermatology, 33, pp. 443 - 445, http://dx.doi.org/10.1111/j.1365-2230.2007.02668.x
,2008, 'Quality of life evaluation in epidermolysis bullosa', Journal of the American Academy of Dermatology, 58, pp. AB81 - AB81
,2008, 'Quality of life evaluation in epidermolysis bullosa: Development of the QOLEB questionnaire', Journal of Investigative Dermatology, 128, pp. 1607 - 1607
,2008, 'Reticular variant of mid-dermal elastolysis', American Journal of Dermatopathology, 30, pp. 287 - 290
,2008, 'Treatment of pemphigus - The need for more evidence', Archives of Dermatology, 144, pp. 100 - 101
,2007, 'Randomised controlled trial of minigrafting versus recell in stable vitiligo', Journal of Investigative Dermatology, 127, pp. 2685 - 2685, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250226800052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2007, 'Recessive epidermolysis bullosa simplex due to a homozygous truncation mutation KRT14 Y204X with basal K6/16 expression and an ameliorating phenotype', Journal of Investigative Dermatology, 127, pp. 2690 - 2690, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250226800067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2007, 'Cutaneous Mycobacterium neoaurum infection causing scarring alopecia in an immunocompetent host', British Journal of Dermatology, 157, pp. 204 - 206
,2007, 'Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparaesthesia', Australasian Journal of Dermatology, 48, pp. 40 - 42
,2006, 'A complicated blistering disease case demonstrating the usefulness of immunoblotting and ELISA for the diagnosis of immunobullous diseases', Australasian Journal of Dermatology, 47, http://dx.doi.org/10.1111/j.1440-0960.2006.00311_3.x
,2006, 'Interventions for pemphigus vulgaris and pemphigus foliaceus', Cochrane Database of Systematic Reviews, pp. 1 - 16
,2005, 'The preparation of dermal and epidermal protein extracts for the detection of autoimmune bullous disorders using an immunoblotting technique', Journal of Investigative Dermatology, 125, pp. A12 - A12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233823900070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2005, 'Gorlin`s Syndrome', Medical Observer, June 2005, pp. 30 - 30
,